Table 2.
Animal Model | Diet | Duration | Outcome | References |
---|---|---|---|---|
Male C57BL/6 mice Wild-type and ob/ob | Standard diet (4% fat) ± curcumin 3% by weight HFD (35% fat) ± curcumin 3% by weight (n = 5/group) |
6-weeks | in adipose tissue ↑Foxo1 and adiponectin expression ↓infiltration of macrophages ↑circulating Adiponectin levels ↓MCP-1. ↓TNFα, MCP-1 expression, and NF-κB activity in liver |
[72] |
Male Sprague Dawley rats | Standard diet (control) HFD HFD + curcumin (80 mg/kg/day) (n = 11/group) |
60 days 75 days |
↓FFA and TNFα serum levels in all group compared to non-treated HFD groups | [73] |
Male C57BL/6J mice | Low-fat diet (10% Kcal from fat) HFD (45% Kcal from fat) HFD + curcumin (4 g/kg diet) (n = 12/group) |
28 weeks | in adipose tissue ↓macrophage infiltration ↓NF-κB expression and JNK signaling pathway activation |
[74] |
Male C57BL/6J mice | Standard Diet (control) HFD HFD + Curcuma-P® (0.1% curcumin + 0.01% white pepper) (n = 8/group) |
4 weeks | ↓IL-6 and TNFα, no changes in MCP1, IL-1β, CD68, and F4/80 in adipose tissue | [75] |
Male C57BL/6 mice | HFD HFD + curcumin (50 mg/kg) (n = 6/group) |
10 days | ↓ER stress in adipose tissue ↓FFA release from adipose tissue |
[79] |
Male Wistar rats | Standard diet (control) HFD HFD + curcuminoid (30, 60, 90 mg\Kg body weigth\day) (n = 12/group) |
12 weeks | ↓FFA plasma levels | [80] |
Cell type | ||||
Raw 264.7 macrophages treated with conditioned medium by mesenteric adipose tissue 3T3-L1 adipocytes |
0.1–1–10 µM curcumin 10 µM curcumin |
24 h | ↓TNFα and MCP-1 release ↓MCP-1 release |
[86] |
3T3-L1 adipocytes treated with TNF-α | 2–20 μM curcumin | 62 h | ↓NF-κB activation. ↓TNFα, IL-1β, IL-6, expression ↓IL-6 secretion |
[81] |
3T3-L1 adipocytes 24-h hypoxia | 5, 10, 20 mM curcumin | 24 h | ↓TNFα, IL-1β, IL-6 release | [82] |
THP-1 macrophages treated with PMA | 6.25, 12.5, 25 μM curcumin | 24 h | ↓NLRP3 inflammasome expression, caspase-1 activation, IL-1β secretion, TLR4 expression, and NF-κB activation |
[87] |
Mouse, bone marrow-derived macrophages (BMDM) treated with nigericin (10 mM) THP-1 cells treated with LPS |
30–50 μM curcumin 30–50 μM curcumin |
1 h | ↓caspase-1 cleavage ↓IL-1β secretion ↓caspase-1 activation ↓IL-1β secretion |
[88] |
Abbreviations: ↑ Increases; ↓ Decreases; IL-6, interleukin-6; IL-1β, interleukin-1β; MCP-1, monocyte chemoattractant protein-1; TNFα, tumor necrosis factor α; FFA, free fatty acids; HFD, high-fat diet; ER, endoplasmic reticulum; LPS, lipopolysaccharides; PMA, phorbol 12-myristate 13-acetate; Foxo1, forkhead transcription factor 1; NF-κB, nuclear transcriptor factor kappa B; JNK, jun N-terminal kinase; TLR4, toll-like receptor 4; NLRP3, nod-like receptor pyrin domain-containing 3.